These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND ERG, P11308, 2078 AND Treatment
90 results:

  • 1. Enhancer looping protein LDB1 modulates MYB expression in T-ALL cell lines in vitro by cooperating with master transcription factors.
    Li Y; Zhang Z; Yu J; Yin H; Chu X; Cao H; Tao Y; Zhang Y; Li Z; Wu S; Hu Y; Zhu F; Gao J; Wang X; Zhou B; Jiao W; Wu Y; Yang Y; Chen Y; Zhuo R; Yang Y; Zhang F; Shi L; Hu Y; Pan J; Hu S
    J Exp Clin Cancer Res; 2024 Oct; 43(1):283. PubMed ID: 39385230
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Germ line erg haploinsufficiency defines a new syndrome with cytopenia and hematological malignancy predisposition.
    Zerella JR; Homan CC; Arts P; Lin X; Spinelli SJ; Venugopal P; Babic M; Brautigan PJ; Truong L; Arriola-Martinez L; Moore S; Hollins R; Parker WT; Nguyen H; Kassahn KS; Branford S; Feurstein S; Larcher L; Sicre de Fontbrune F; Demirdas S; de Munnik S; Antoine-Poirel H; Brichard B; Mansour S; Gordon K; Wlodarski MW; Koppayi A; Dobbins S; Mutsaers PGNJ; Nichols KE; Oak N; DeMille D; Mao R; Crawford A; McCarrier J; Basel D; Flores-Daboub J; Drazer MW; Phillips K; Poplawski NK; Birdsey GM; Pirri D; Ostergaard P; Simons A; Godley LA; Ross DM; Hiwase DK; Soulier J; Brown AL; Carmichael CL; Scott HS; Hahn CN
    Blood; 2024 Oct; 144(17):1765-1780. PubMed ID: 38991192
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. High DOCK1 expression identifies a distinct prognostic subgroup of pediatric acute myeloid leukemia: Results of the Japanese Pediatric leukemia/Lymphoma Study Group AML-05 trial.
    Yoshitomi M; Tsujimoto SI; Ikeda J; Kawai T; Ohki K; Hara Y; Yamato G; Tanoshima R; Tomizawa D; Shimada A; Horibe K; Adachi S; Taga T; Tawa A; Hayashi Y; Ito S; Shiba N
    Pediatr Blood Cancer; 2024 Sep; 71(9):e31151. PubMed ID: 38953149
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Immunophenotypic clustering in paediatric acute myeloid leukaemia.
    Liu H; Wu K; Hu W; Chen X; Tang Y; Ma Y; Chen C; Xie Y; Yu L; Huang J; Shen S; Wang X
    Br J Haematol; 2024 Jun; 204(6):2275-2286. PubMed ID: 38639201
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Transcriptome Analysis in Mexican Adults with Acute Lymphoblastic leukemia.
    Cruz-Miranda GM; Olarte-Carrillo I; Bárcenas-López DA; Martínez-Tovar A; Ramírez-Bello J; Ramos-Peñafiel CO; García-Laguna AI; Cerón-Maldonado R; May-Hau D; Jiménez-Morales S
    Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339034
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Preclinical efficacy of targeting epigenetic mechanisms in AML with 3q26 lesions and EVI1 overexpression.
    Birdwell CE; Fiskus W; Kadia TM; Mill CP; Sasaki K; Daver N; DiNardo CD; Pemmaraju N; Borthakur G; Davis JA; Das K; Sharma S; Horrigan S; Ruan X; Su X; Khoury JD; Kantarjian H; Bhalla KN
    Leukemia; 2024 Mar; 38(3):545-556. PubMed ID: 38086946
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Oral Azacitidine for Maintenance treatment of Acute Myeloid Leukaemia After Induction Therapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
    Witlox W; Grimm S; Howick J; Armstrong N; Ahmadu C; McDermott K; Otten T; Noake C; Wolff R; Joore M
    Pharmacoeconomics; 2023 Aug; 41(8):857-867. PubMed ID: 37129774
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Integrative genomic analysis of childhood acute lymphoblastic leukaemia lacking a genetic biomarker in the UKALL2003 clinical trial.
    Schwab C; Cranston RE; Ryan SL; Butler E; Winterman E; Hawking Z; Bashton M; Enshaei A; Russell LJ; Kingsbury Z; Peden JF; Barretta E; Murray J; Gibson J; Hinchliffe AC; Bain R; Vora A; Bentley DR; Ross MT; Moorman AV; Harrison CJ
    Leukemia; 2023 Mar; 37(3):529-538. PubMed ID: 36550215
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The kinetics of blast clearance are associated with copy number alterations in childhood B-cell acute lymphoblastic leukemia.
    Urbańska Z; Lejman M; Taha J; Madzio J; Ostrowska K; Miarka-Walczyk K; Wypyszczak K; Styka B; Jakubowska J; Sędek Ł; Szczepański T; Stańczak M; Fendler W; Młynarski W; Pastorczak A
    Neoplasia; 2023 Jan; 35():100840. PubMed ID: 36288679
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. TLS/FUS-erg fusion gene in acute leukemia and myelodysplastic syndrome evolved to acute leukemia: report of six cases and a literature review.
    Zhang H; Zhan Q; Wang X; Gao F; Yu J; Wang J; Fu W; Wang P; Wei X; Zhang L
    Ann Hematol; 2022 Dec; 101(12):2583-2600. PubMed ID: 36181538
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. EVI1 drives leukemogenesis through aberrant erg activation.
    Schmoellerl J; Barbosa IAM; Minnich M; Andersch F; Smeenk L; Havermans M; Eder T; Neumann T; Jude J; Fellner M; Ebert A; Steininger M; Delwel R; Grebien F; Zuber J
    Blood; 2023 Feb; 141(5):453-466. PubMed ID: 36095844
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Targeted treatment and Immunotherapy in High-risk and Relapsed/ Refractory Pediatric Acute Lymphoblastic leukemia.
    Graiqevci-Uka V; Behluli E; Spahiu L; Liehr T; Temaj G
    Curr Pediatr Rev; 2023; 19(2):150-156. PubMed ID: 36056858
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120.
    Fazio G; Bresolin S; Silvestri D; Quadri M; Saitta C; Vendramini E; Buldini B; Palmi C; Bardini M; Grioni A; Rigamonti S; Galbiati M; Mecca S; Savino AM; Peloso A; Tu JW; Bhatia S; Borkhardt A; Micalizzi C; Lo Nigro L; Locatelli F; Conter V; Rizzari C; Valsecchi MG; Te Kronnie G; Biondi A; Cazzaniga G
    EBioMedicine; 2022 Sep; 83():104224. PubMed ID: 35985167
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The transformation of isolated gastric myeloid sarcoma into acute myeloid leukemia presenting with a complex karyotype and TLS-erg gene fusion: A case report.
    Gao L; Xu Y; Tian Z; Xia J; Yuan Z; Chen D; Ren M
    Medicine (Baltimore); 2022 May; 101(21):e29475. PubMed ID: 35623083
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Genetic and genomic analysis of acute lymphoblastic leukemia in older adults reveals a distinct profile of abnormalities: analysis of 210 patients from the UKALL14 and UKALL60+ clinical trials.
    Creasey T; Barretta E; Ryan SL; Butler E; Kirkwood AA; Leongamornlert D; Papaemmanuil E; Patrick P; Clifton-Hadley L; Patel B; Menne T; McMillan AK; Harrison CJ; Rowntree CJ; Morley N; Marks DI; Fielding AK; Moorman AV
    Haematologica; 2022 Sep; 107(9):2051-2063. PubMed ID: 34788984
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Genetic characterisation of childhood B-other-acute lymphoblastic leukaemia in UK patients by fluorescence in situ hybridisation and Multiplex Ligation-dependent Probe Amplification.
    Schwab CJ; Murdy D; Butler E; Enshaei A; Winterman E; Cranston RE; Ryan S; Barretta E; Hawking Z; Murray J; Antony G; Vora A; Moorman AV; Harrison CJ
    Br J Haematol; 2022 Feb; 196(3):753-763. PubMed ID: 34676543
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Proposal and clinical application of molecular genetic risk scoring system, "MRplus", for BCR-ABL1 negative pediatric B-cell acute lymphoblastic leukemia- report from a single centre.
    Gupta SK; Bakhshi S; Kamal VK; Gupta R; Sharma P; Pushpam D; Sahoo RK; Sharma A
    Leuk Res; 2021 Dec; 111():106683. PubMed ID: 34371436
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. An inhibitor of endothelial ETS transcription factors promotes physiologic and therapeutic vessel regression.
    Schafer CM; Gurley JM; Kurylowicz K; Lin PK; Chen W; Elliott MH; Davis GE; Bhatti F; Griffin CT
    Proc Natl Acad Sci U S A; 2020 Oct; 117(42):26494-26502. PubMed ID: 33020273
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. FLI1 and erg protein degradation is regulated via Cathepsin B lysosomal pathway in human dermal microvascular endothelial cells.
    Mazzotta C; Marden G; Farina A; Bujor A; Trojanowski MA; Trojanowska M
    Microcirculation; 2021 Jan; 28(1):e12660. PubMed ID: 32979864
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Trib1 promotes acute myeloid leukemia progression by modulating the transcriptional programs of Hoxa9.
    Yoshino S; Yokoyama T; Sunami Y; Takahara T; Nakamura A; Yamazaki Y; Tsutsumi S; Aburatani H; Nakamura T
    Blood; 2021 Jan; 137(1):75-88. PubMed ID: 32730594
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.